Download presentation
Presentation is loading. Please wait.
Published byErlin Kartawijaya Modified over 6 years ago
1
Getting the Best out of Guidelines in the Rapidly Changing Landscape of RA Treatment
3
Introduction/Background
4
Guidelines for the Treatment of RA
5
ACR Guidelines for Treatment of Early RA
6
Preliminary EULAR Guidelines: 2016
7
RA Treatment Goals in the 21st Century: EULAR and ACR
8
T2T Approach to RA Therapeutics
9
Use of Corticosteroids in RA: Comparison of an Attenuated Combination Strategy (“COBRA-light”) Compared With the Original COBRA Strategy
10
Concerns Regarding Use of Corticosteroids in RA
11
Delayed Intervention May Mean Irreparable Loss of Function
12
EULAR Overarching Principles Regulating the Treatment of RA
13
Critique of Current RA Guidelines
14
Approaches for the Nonresponding Patient in RA
15
Types of Therapies for RA
16
JAK Inhibitors
17
Guidelines: Broad Range of Pharmacotherapies Available, But No Clear Selection Criteria
18
An Approach to Personalized Medicine
19
Taking Into Account Patient Preferences
20
The Importance of Physician/Patient Communication
21
Preliminary EULAR Guidelines: 2016
22
Safety Concerns With bDMARDs in RA
23
Appropriate Management of RA
24
Prevention of RA by B-Cell-Directed Therapy in the Earliest Phase of the Disease: The PRAIRI Study
25
RA Guidelines: Practice What You Preach?
26
Three Key Components in the "Lifecycle" of Treatment Guidelines
27
Summary and Conclusions
28
Abbreviations
29
Abbreviations (cont)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.